State Board of Medical Examiners

Guidance re Act 76

Act 76 makes two important changes to the law governing health care practitioners who prescribe controlled dangerous substances. Click HERE for information for CDS Prescribers re Act 76 of the 2017 Regular Session of the Louisiana Legislature.



Clinical Laboratory Advisory Committee Meeting

The clinical laboratory advisory committee meeting that was scheduled for Saturday, June 24th at 10:00am at the law firm of Adams & Reese has been canceled due to inclimate weather.


Medical Psychology Advisory Committee Meeting

NOTICE IS HEREBY GIVEN, pursuant to LSA-R.S. 42:7(A), that the Medical Psychology Advisory Committee, a Committee under the Louisiana State Board of Medical Examiners, State of Louisiana, shall convene a meeting of the Committee at 913 South College, Suite 102, Lafayette at 12:00 p.m., Thursday, April 20, 2017. AGENDA



"Opioid Prescribing: A Provider Discussion" hosted by Medicaid

Dear Colleagues,

Louisiana Medicaid will host the March Lunch & Learn webinar for providers, “Opioid Prescribing: A Provider Discussion”, on Wednesday, March 29, at 12:00 – 1pm.  Please join us for this free educational, online webinar about opioid prescribing. 

Our featured topics include:

·         CDC Guidelines on Opioid Prescribing

·         Updates on Louisiana Medicaid Opioid Initiatives

Please register for this educational Lunch & Learn webinar, “Opioid Prescribing: A Provider Discussion” March 29, 2016, 12:00 NOON CST at: 

After registering, you will receive a confirmation email containing information about joining the webinar.  Note: Due to technology constraints, the webinar is limited to 100 attendees.  Early registration is encouraged.

Please forward to anyone who may be interested.  For more Information click HERE.



LA Medicaid's Town Hall Meetings

LA Medicaid is pleased to announce a series of town hall meetings to solicit input from medical providers in this state. Click here for more information.



25% Decrease in opioid production in 2017

The DEA has issued a press release announcing its intent to decrease opioid production in 2017 by 25%.  Physicians should be aware of this and consider making adjustments to their prescribing practices. See Here